May 02, 2011
A federal judge in Washington on Monday tossed Mylan Pharmaceuticals Inc.'s suit to compel the U.S. Food and Drug Administration to weigh in on Ranbaxy Laboratories Ltd.'s exclusivity provision for marketing a generic version of Lipitor.
April 28, 2011
Mylan Pharmaceuticals Inc. asked a Washington federal judge on Thursday not to toss its suit seeking to compel the U.S. Food and Drug Administration to remove the exclusivity provision from Ranbaxy Laboratories Ltd.'s dormant first-filed abbreviated new drug application for Lipitor.
April 07, 2011
The U.S. Food and Drug Administration on Monday asked a Washington court to throw out a suit by Mylan Pharmaceuticals Inc. seeking to force the agency to strip Ranbaxy Laboratories Ltd. of the exclusive right to sell generic Lipitor, a cholesterol drug.